Li, J.; Zhang, X.; Tian, J.; Li, J.; Li, X.; Wu, S.; Liu, Y.; Han, J.; Ye, F.
CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease. Pharmaceuticals 2023, 16, 106.
https://doi.org/10.3390/ph16010106
AMA Style
Li J, Zhang X, Tian J, Li J, Li X, Wu S, Liu Y, Han J, Ye F.
CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease. Pharmaceuticals. 2023; 16(1):106.
https://doi.org/10.3390/ph16010106
Chicago/Turabian Style
Li, Jiang, Xiaolin Zhang, Jinying Tian, Juan Li, Xuechen Li, Song Wu, Yuying Liu, Jingyan Han, and Fei Ye.
2023. "CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease" Pharmaceuticals 16, no. 1: 106.
https://doi.org/10.3390/ph16010106
APA Style
Li, J., Zhang, X., Tian, J., Li, J., Li, X., Wu, S., Liu, Y., Han, J., & Ye, F.
(2023). CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease. Pharmaceuticals, 16(1), 106.
https://doi.org/10.3390/ph16010106
